Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
FECS-Ad
- Development stage
- Phase 2
- Lead developer
- S.Biomedics
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intramuscular
01
Overview
FECS-Ad is an allogeneic cell therapy consisting of three-dimensional (3D) clusters of adipose-derived mesenchymal stem cells (MSCs). Developed by S.Biomedics using their proprietary Functionally Enhanced Cell Sphere (FECS) technology, the product organizes cells into spheroids to enhance their survival, engraftment, and therapeutic potency compared to standard 2D-cultured single-cell suspensions. The therapy is primarily being investigated for the treatment of critical limb ischemia (CLI), where it aims to promote revascularization and tissue regeneration through the secretion of various angiogenic and anti-inflammatory factors, such as VEGF and HGF. By delivering these cell clusters via intramuscular injection, the treatment seeks to restore blood flow and prevent amputation in patients with advanced peripheral artery disease.
- Other names
- 3D-AAdipose-derived mesenchymal stem cell clustersFunctionally enhanced cell spheres-adipose
Beyond the preview
Go deeper on FECS-Ad.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on FECS-Ad.